Corpus StriatumLevodopaDopamineReceptors, DopamineReceptors, Dopamine D23,4-Dihydroxyphenylacetic AcidAntiparkinson AgentsBrainCarbidopaDopamine AgonistsReceptors, Dopamine D1BerberineSubstantia NigraCorpus LuteumDopamine AntagonistsCorpus CallosumDopamine AgentsReceptors, Dopamine D3Parkinson DiseaseBenserazideRats, Inbred StrainsDyskinesia, Drug-InducedDopamine Plasma Membrane Transport ProteinsRats, Sprague-DawleyNeuronsAgenesis of Corpus CallosumDihydroxyphenylalanineNeostriatumDopamine Uptake InhibitorsTrihexyphenidylApomorphineReceptors, Dopamine D5Basal GangliaDopamine beta-HydroxylaseOxidopamineRacloprideParkinson Disease, SecondaryHomovanillic AcidParkinsonian DisordersBromocriptineErgolinesQuinpiroleBenzazepinesNucleus AccumbensTyrosine 3-MonooxygenasePutamenDopamine and cAMP-Regulated Phosphoprotein 32Caudate NucleusDyskinesiasHaloperidolCocaineMicrodialysisLisurideSelegilineAmphetamineSulpirideBehavior, AnimalSalicylamidesDopa DecarboxylaseCorpora AllataMesencephalonMotor ActivityDopaminergic NeuronsRewardBenzophenonesSpiperoneSubthalamic NucleusCatechol O-MethyltransferaseMovement DisordersGlobus PallidusDystoniaDose-Response Relationship, Drug1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridinePenisMPTP PoisoningParkinson Disease, PostencephaliticMethamphetamineNomifensineCorpus Luteum MaintenanceNeural PathwaysAnalysis of VarianceMagnetic Resonance Imagingalpha-MethyltyrosineBenzothiazolesTime FactorsDeep Brain StimulationMonoamine Oxidase InhibitorsTetrabenazineVentral Tegmental AreaTropanesLuteolysisMotor SkillsBiogenic MonoaminesPergolideProgesteroneBrain ChemistryRats, WistarMuscle RigidityStereotyped BehaviorNerve Tissue Proteins